HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$1.46
Day range
$1.45 - $1.50
Year range
$1.23 - $2.26
Market cap
25.10M USD
Avg Volume
36.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.86M | -38.37% |
Net income | -5.28M | 65.84% |
Net profit margin | — | — |
Earnings per share | -0.31 | 63.53% |
EBITDA | -6.76M | 41.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 33.98M | -50.81% |
Total assets | 53.52M | -47.01% |
Total liabilities | 33.77M | -34.56% |
Total equity | 19.75M | — |
Shares outstanding | 16.85M | — |
Price to book | 1.25 | — |
Return on assets | -31.05% | — |
Return on capital | -36.66% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.28M | 65.84% |
Cash from operations | -4.58M | 58.64% |
Cash from investing | 4.67M | -52.61% |
Cash from financing | 68.00K | 102.59% |
Net change in cash | 154.00K | 104.00% |
Free cash flow | -1.85M | 71.11% |
About
Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
19